Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Immune Design Corp Company Profile (NASDAQ:IMDZ)

Consensus Ratings for Immune Design Corp (NASDAQ:IMDZ) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00 (42.22% downside)

Analysts' Ratings History for Immune Design Corp (NASDAQ:IMDZ)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/19/2014Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Jefferies GroupInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/24/2012 forward)
Discuss Immune Design Corp